MedPath

FDA Revokes Emergency Use Authorization for Evusheld

FDA revoked authorization for Evusheld due to its ineffectiveness against recent SARS-CoV-2 variants like XBB.1.5, now responsible for most infections. Other treatments remain effective.


Reference News

FDA Revokes Emergency Use Authorization for Evusheld

FDA revoked authorization for Evusheld due to its ineffectiveness against recent SARS-CoV-2 variants like XBB.1.5, now responsible for most infections. Other treatments remain effective.

© Copyright 2025. All Rights Reserved by MedPath